Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Assets Average: 2022-2024

Historic Assets Average for Kiniksa Pharmaceuticals International (KNSA) over the last 3 years, with Dec 2024 value amounting to $553.4 million.

  • Kiniksa Pharmaceuticals International's Assets Average rose 25.12% to $686.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $686.7 million, marking a year-over-year increase of 25.12%. This contributed to the annual value of $553.4 million for FY2024, which is 12.26% up from last year.
  • According to the latest figures from FY2024, Kiniksa Pharmaceuticals International's Assets Average is $553.4 million, which was up 12.26% from $493.0 million recorded in FY2023.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Assets Average registered a high of $553.4 million during FY2024, and its lowest value of $346.2 million during FY2022.
  • Over the past 3 years, Kiniksa Pharmaceuticals International's median Assets Average value was $493.0 million (recorded in 2023), while the average stood at $464.2 million.
  • Data for Kiniksa Pharmaceuticals International's Assets Average shows a peak YoY soared of 42.39% (in 2023) over the last 5 years.
  • Over the past 3 years, Kiniksa Pharmaceuticals International's Assets Average (Yearly) stood at $346.2 million in 2022, then spiked by 42.39% to $493.0 million in 2023, then grew by 12.26% to $553.4 million in 2024.